APRI Announces First Patient Enrolled In Phase 2a Trial For RayVa
TM Editors’ Note: One or more of the stocks discussed in this article is a penny stock and/or microcap. Such stocks are easily manipulated; do your own due diligence. Below is a look at some of the headlines for companies that made news in the healthcare sector on December 4, 2014. Apricus Biosciences, Inc. (Nasdaq:APRI),…